Insider buying on Jun 10, 2026
Insiders at 14 companies reported 42 open-market buys of their own stock on Jun 10, 2026. Plan trades are left out.
Newest first
WhoTradeCompanyValueTradedThe stock’s closing price from the first session on or after the trade day to the latest close, with the S&P 500 over the same days. A fact about the stock, not a result anyone earned.
Vivo OpportunityMajor shareholderBoughtRaised their holding by 4.3%
InMed PharmaceuticalsINM$4.5K2,982 shares at $1.52Jun 8140d agoStock since trade+3.3%Jun 8, 2026 close $1.54 → Oct 26, 2026 close $1.59. S&P 500 +3.5% over the same days.
Vivo OpportunityMajor shareholderBoughtRaised their holding by 4.3%InMed PharmaceuticalsINM$44.9K29,518 shares at $1.52Jun 8140d agoStock since trade+3.3%Jun 8, 2026 close $1.54 → Oct 26, 2026 close $1.59. S&P 500 +3.5% over the same days.
Vivo OpportunityMajor shareholderBoughtRaised their holding by 7.9%InMed PharmaceuticalsINM$7.9K5,045 shares at $1.57Jun 5143d agoStock since trade+0.6%Jun 5, 2026 close $1.58 → Oct 26, 2026 close $1.59. S&P 500 +3.8% over the same days.
Vivo OpportunityMajor shareholderBoughtRaised their holding by 7.9%InMed PharmaceuticalsINM$78.4K49,966 shares at $1.57Jun 5143d agoStock since trade+0.6%Jun 5, 2026 close $1.58 → Oct 26, 2026 close $1.59. S&P 500 +3.8% over the same days.
Vivo OpportunityMajor shareholderBoughtRaised their holding by 1.0%InMed PharmaceuticalsINM$970.26618 shares at $1.57Jun 4144d agoStock since trade+1.9%Jun 4, 2026 close $1.56 → Oct 26, 2026 close $1.59. S&P 500 +1.1% over the same days.
Vivo OpportunityMajor shareholderBoughtRaised their holding by 1.0%InMed PharmaceuticalsINM$9.6K6,125 shares at $1.57Jun 4144d agoStock since trade+1.9%Jun 4, 2026 close $1.56 → Oct 26, 2026 close $1.59. S&P 500 +1.1% over the same days.
Vivo OpportunityMajor shareholderBoughtRaised their holding by 1.1%InMed PharmaceuticalsINM$1.1K714 shares at $1.55Jun 3145d agoStock since trade+0.0%Jun 3, 2026 close $1.59 → Oct 26, 2026 close $1.59. S&P 500 +1.5% over the same days.
Vivo OpportunityMajor shareholderBoughtRaised their holding by 1.1%InMed PharmaceuticalsINM$11K7,069 shares at $1.55Jun 3145d agoStock since trade+0.0%Jun 3, 2026 close $1.59 → Oct 26, 2026 close $1.59. S&P 500 +1.5% over the same days.
Vivo OpportunityMajor shareholderBoughtRaised their holding by 3.4%InMed PharmaceuticalsINM$3.2K2,095 shares at $1.52Jun 2146d agoStock since trade+4.6%Jun 2, 2026 close $1.52 → Oct 26, 2026 close $1.59. S&P 500 +0.8% over the same days.
Vivo OpportunityMajor shareholderBoughtRaised their holding by 3.4%InMed PharmaceuticalsINM$31.5K20,753 shares at $1.52Jun 2146d agoStock since trade+4.6%Jun 2, 2026 close $1.52 → Oct 26, 2026 close $1.59. S&P 500 +0.8% over the same days.